[ad_1]
Pfizer Covid-19 Vaccine (REUTERS / Dado Ruvic)
SÃO PAULO – The pharmaceutical company Pfizer will deliver 14 million doses from your Covid-19 vaccine, produced in association with the German laboratory BioNTech, to Brazil until June 2021.
The information was given by the special adviser of the Ministry of Health, Airton Soligo, in a conversation with the press in the Palácio do Planalto, this Monday (8), after a videoconference of President Jair Bolsonaro (without party) with representatives of the business. .
The measure represents the anticipation of the delivery of 5 million doses. The immunizers were scheduled for the second semester, but now they are for the months of May and June, adding to the 9 million doses already planned for the period (2 million in May and 7 million in June).
Brazil negotiates a total of 99 million doses with Pfizer by the end of the year and tries to get ahead of the deadlines, amid the resurgence of the health crisis, with an explosion of cases and deaths caused by the disease and a spike in hospitalizations in units. of health. of all country.
“TO [entrega da] the vast majority of Pfizer vaccines were [prevista] in October, November and December. The president will make an effort to move it from the last quarter to the third quarter, ”Soligo said.
The immunizer is the only one with a definitive registration granted by the National Health Surveillance Agency (Anvisa), but it has not yet been applied by the National Immunization Program. For now, Brazil only has the CoronaVac vaccines, produced by the Chinese laboratory Sinovac in association with the Butantan Institute, and Oxford / AstraZeneca, in local association with the Oswaldo Cruz Foundation.
Minister Paulo Guedes (Economy) also spoke with journalists at the Planalto Palace and said that Brazil obtained “practically a declaration that the agreement is closed” with Pfizer. However, the contract has not yet been signed. “This was the agreement between the President of the Republic and the President of Pfizer [Albert Bourla]. Is closed. Now they are going to write, sign, ”he said.
To the press, Guedes affirmed that pharmaceutical production must go from 1.5 million daily doses to 5 million, which will allow anticipating the delivery schedule for Brazil and other countries. The evolution of the negotiations takes place more than a month after the start of the vaccination campaign in the country.
Faced with criticism for the delay in negotiations with pharmaceutical companies and the slowness in the vaccination campaign, the head of the economic team said that immunizing the population is the government’s priority. “Mass vaccination is the government’s first priority,” he said. “We are going to vaccinate and keep the economy moving,” he added.
After delivering the 14 million doses, the lab should have at least 10 million more doses available from July through October, Soligo said. THE InfoMoney has contacted Pfizer and is awaiting confirmation of delivery of the 14 million immunizers.
Bolsonaro’s meeting with Pfizer representatives was not on the presidential agenda and was seen as a response by the president to criticism directed at the federal government for addressing the new coronavirus pandemic. Yesterday (7), Brazil registered 1,054 new deaths from the disease and, for the ninth consecutive day, it maintained a record in the moving average of deaths in seven days, with 1,497 registrations.
Since the start of the pandemic, 265,500 Brazilians have died from Covid-19. 11,018,557 cases were registered.
Vaccination in Brazil
Pfizer’s Covid-19 vaccine, developed jointly with the German laboratory BioNTech, has been applied in the United States and the United Kingdom since December, in addition to being the most widely used immunizer in Israel.
Considered one of the most effective immunizers in the world to date, the vaccine faced resistance from the government due to clauses that provided for the transfer of responsibility. Even so, the immunizer Pfizer / BioNTech was the only one to obtain a definitive registration granted by the National Health Surveillance Agency (Anvisa).
The country uses vaccines for now CoronaVac (produced by the Butantan Institute in association with the Chinese laboratory Sinovac) and Oxford / Astrazeneca (produced by the British university and the pharmaceutical company, in a local alliance with the Oswaldo Cruz Foundation, Fiocruz). Both received approval from Anvisa for emergency use, not for definitive registration.
Asked about the delays in negotiations with Pfizer, Soligo said the previous deal could not be closed due to contractual clauses, without going into details. Last Sunday (7), the newspaper Folha de S.Paulo revealed that, in 2019, the Brazilian government rejected Pfizer’s proposal that it expected the delivery of 70 million vaccines by December this year, 3 million by February.
Soligo told reporters that if the agreement had been signed, Brazil would have received 500,000 doses in January, 500,000 doses in February, and 1 million in March. He maintained that the amount was “incorporated” with the anticipation of deliveries for May and June. The government has yet to receive doses of Pfizer.
Are you stuck in your profession? InfoMoney’s free series shows how you can become a stock analyst in 2021. Click here to register.
[ad_2]
